Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NF1 × mirdametinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1 CNS 1

Conditions

Neurofibromatoses 3 Neurofibromatosis 1 2 Neurofibroma, Plexiform 2 Neurofibroma 2 Colorectal Neoplasms 2 Vascular Malformations 1 Skin Diseases, Vascular 1 Primary Malignant Peripheral Nerve Sheath Tumors 1 NF1 1 Melanoma 1 Lymphatic Abnormalities 1 Lymphangioma, Cystic 1 Lymphangioma 1 Liposarcoma, Myxoid 1 Liposarcoma 1 KRAS Mutant Non-Small Cell Lung Cancer 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1 Arteriovenous Malformations 1 Advanced Solid Tumor 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06159166 2025-04-23

Mirda

Johns Hopkins University

Phase 1/2 Recruiting

CNSDermatologic

NF1

Data powered by HemOnc (CC BY 4.0) Colophon ⚡